News

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...
Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...
Pfizer Inc. (NYSE:PFE) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 10, Pfizer Inc. (NYSE:PFE) shared ...
The completion of this study may positively influence Pfizer’s stock performance by demonstrating the effectiveness and safety of INLYTA® in real-world settings, potentially boosting investor ...
Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...
Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...
As different stocks rise and fall, so do dividend yields, creating a shifting landscape of opportunities for income-oriented ...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Pfizer is warning physicians that it expects a new shortage of Bicillin L-A, a long-acting penicillin injection that is currently the single recommended treatment for syphilis during pregnancy, CNN ...
This was the stock's third consecutive day of losses.
The purpose of investing in stocks is to make money, not lose it. So selling shares at a loss can be very upsetting. In this ...